PEG Ratio
Updated 248h ago
Sector Performance
91th percentileTROW
6.26x
Sector Median
0.94x
Sector Avg
3.01x
Deep Analysis
The PEG ratio (price/earnings-to-growth) measures a stock's price relative to its earnings growth rate; a ratio of 6.26x suggests the stock is priced at over six times its expected earnings growth, which is considered expensive if growth does not accelerate.
Compared to the sector median of 0.92x, TROW’s PEG is much higher, placing it in the 92nd percentile among peers — meaning only 8% of sector stocks carry a higher PEG. The trend has been increasing over the last eight quarters, with a year-over-year change not available and a quarter-over-quarter increase of +645.2% from the prior value of 0.84x. A combination of a very elevated PEG level and a rapidly rising trend indicates that investors are paying a premium for growth expectations that may or may not materialize, increasing the risk of valuation compression if growth disappoints. This metric contradicts the overall NEUTRAL verdict, as the high and climbing PEG ratio typically signals a stretched valuation that warrants caution rather than neutrality.
Frequently Asked Questions
What does the PEG Ratio tell investors about TROW?
The PEG ratio adjusts P/E for expected growth. A PEG below 1.0 may signal undervaluation; above 2.0 may suggest the growth story is priced in.
How is the PEG Ratio calculated?
PEG Ratio is calculated as: P/E Ratio / EPS Growth Rate.
Who are TROW's closest peers by PEG Ratio?
The closest peers by PEG Ratio include: NUE (0.06x), VLO (0.06x), LNC (0.05x), NKE (0.05x), NCLH (0.05x).
The Formula
P/E Ratio / EPS Growth Rate
Why It Matters
The PEG ratio adjusts P/E for expected growth. A PEG below 1.0 may signal undervaluation; above 2.0 may suggest the growth story is priced in.
Master TROW's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full TROW research report →TROW
6.26x
Sector Median
0.94x
Sector Avg
3.01x
How TROW's PEG Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.